• OPEN AN ACCOUNT
Indian Indices
Nifty
26,202.95 -12.60
(-0.05%)
Sensex
85,706.67 -13.71
( -0.02%)
Bank Nifty
59,752.70 15.40
( 0.03%)
Nifty IT
37,405.50 -40.80
( -0.11%)
Global Indices
Nasdaq
47,448.12 314.66
(0.67%)
Dow Jones
6,833.61 46.73
(0.69%)
Hang Seng
50,220.95 53.85
(0.11%)
Nikkei 225
9,688.31 -3.27
(-0.03%)
Forex
USD-INR
89.20 0.05
(0.06%)
EUR-INR
103.32 0.40
(0.39%)
GBP-INR
117.74 0.57
(0.49%)
JPY-INR
0.57 0.00
(0.07%)

EQUITY - MARKET SCREENER

Ducol Organics & Colours Ltd
Industry :  Dyes And Pigments
BSE Code
ISIN Demat
Book Value()
78079
INE0LZO01015
55.4883995
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DUCOL
63.38
292.58
EPS(TTM)
Face Value()
Div & Yield %
2.84
10
0
 

Marksans Pharma’s arm gets USFDA approval for Loperamide Hydrochloride 2mg tablets
Nov 19,2025

The approved product is bioequivalent to the reference listed drug (RLD), Imodium A-D Tablets, 2 mg, marketed by Kenvue Brands LLC (NDA - 019860).

Loperamide Hydrochloride is an anti-diarrheal medication used to manage symptoms of acute and chronic diarrhea, strengthening Marksans Pharma’s portfolio in the US generic pharmaceutical market.

Marksans Pharma is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations.

The company’s consolidated net profit rose 1.6% to Rs 98.25 crore on 12.2% jump in revenue from operations to Rs 720.41 crore in Q2 FY26 over Q2 FY25.

Shares of Marksans Pharma fell 1.46% to Rs 189.50 on the BSE.